[1] 谢笃英.早期乳腺癌保乳术与改良根治术的临床疗效比较[J].医学临床研究,2017,34(3):542-545. [2] Wu SP, Tam M, Vega RM,et al. Effect of Breast Irradiation on Cardiac Disease in Women Enrolled in BCIRG-001 at 10-Year Follow-Up [J].Int J Radiat Oncol Biol Phys, 2017, 99(3):541-548. [3] Tiwari A, Gogia A, Deo S,et al. Retrospective study of efficacy and safety of neoadjuvant docetaxel, carboplatin, and trastuzumab in HER2-positive locally advanced and oligometastatic breast cancer: An Indian experience [J].Indian J Cancer,2017,54(1):343-346. [4] Li L, Ni J,Li M,et al. Ginsenoside Rg3 micelles mitigate doxorubicin-induced cardiotoxicity and enhance its anticancer efficacy[J].Drug Deliv,2017 ,24(1):1617-1630. [5] 中国临床肿瘤学会,中华医学会血液学分会. 蒽环类药物心脏毒性防治指南(2013年版)[J].临床肿瘤学杂志,2013,18(10):925-934. [6] Lu Y, Huang H, Yang H,et al. Randomized controlled trial of late-course concurrent versus sequential chemoradiotherapy after mastectomy and axillary surgery in locally advanced breast cancer [J].Medicine (Baltimore),2017,96(41): e8252. [7] 姚慧,邓雪瑜,方秦,等.洛伐他汀对乳腺癌干细胞的体外化疗增敏作用[J].湖南师范大学学报(医学版),2015,12(05):1-3. [8] Cove-Smith L, Woodhouse N, Hargreaves A,et al. An integrated characterization of serological, pathological, and functional events in doxorubicin-induced cardiotoxicity[J].Toxicol Sci,2014,140(1):3-15. [9] 卢章,罗菲菲,邱创华,等.和肽素、磷酸激酶心肌同工酶及高敏肌钙蛋白在急性冠脉综合征中的诊断价值[J].广东医学,2017,38(16):2489-2492.
2019, Vol. 36 
